Leva Clinic, a London, UK-based chronic pain and medical cannabis company, raised $3.5M in funding.
The round was led by Óskare Capital and Justin Hartfield.
The company intends to use the funds to grow the clinic’s reach, strengthen and broaden partnerships with the NHS and other healthcare providers, and improve ongoing patient experience with a mobile app.
Led by CEO Eric Bystrom, Leva Clinic is an online clinic for people living with chronic pain. Regulated by the Care Quality Commission, the company provides services that are accessible through the Boots Health Hub. The clinic also has live partnerships with several NHS trusts to deliver digital therapeutic services and consultant-led patient care plans. Leva is a founding member of Project Twenty21, an observational medical cannabis study in the UK. Leva’s Satoline range of medical cannabis-based medicines is part of the formulary for the trial, gathering evidence on the efficacy of medical cannabis-based medicines.
FinSMEs
09/11/2022